Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Los Angeles, California and other locations
Dates
study started
completion around
Principal Investigator
by Mario C. Deng

Description

Summary

Severe acute respiratory syndrome coronavirus 2-mediated coronavirus disease (COVID-19) is an evolutionarily unprecedented natural experiment that causes major changes to the host immune system. We propose to develop a test that accurately predicts short- and long-term (within one-year) outcomes in hospitalized COVID-19 patients broadly reflecting US demographics who are at increased risk of adverse outcomes from COVID-19 using both clinical and molecular data. We will enroll patients from a hospitalized civilian population in one of the country's largest metropolitan areas and a representative National Veteran's population.

Official Title

Multi-Dimensional Outcome Prediction Algorithm for Hospitalized COVID-19 Patients

Details

Keywords

COVID-19, Post Acute Sequelae of COVID-19, Long COVID, Organ Dysfunction Syndrome, Multiple, Frailty Syndrome, outcome prediction, systems biology, multiomics, algorithm, veterans, high-risk populations, Post-Acute COVID-19 Syndrome, Syndrome, Frailty, Multiple Organ Failure, Blood and nasal swab sampling, civilian, Veteran

Eligibility

Locations

  • Ronald Reagan UCLA Medical Center accepting new patients
    Los Angeles California 90095 United States
  • Olive View-UCLA Education & Research Institute accepting new patients
    Sylmar California 91342 United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center accepting new patients
    Torrance California 90502 United States
  • VA Greater Los Angeles Healthcare System accepting new patients
    Los Angeles California 90073 United States

Lead Scientist at UCLA

  • Mario C. Deng
    Professor-in-Residence, Medicine. Authored (or co-authored) 154 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT05471011
Study Type
Observational
Participants
Expecting 600 study participants
Last Updated